Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems
- PMID: 8229780
Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems
Abstract
Acute administration of cocaine increases expression of the transcription factor genes c-fos and zif268 in the striatum. This response is thought to be mediated via D1 dopamine (DA) receptors, as it is blocked by the selective D1 receptor antagonist SCH 23390. However, the directly acting D1 receptor agonists, apomorphine and SKF 38393, do not mimic cocaine's activation of these genes raising the possibility that D1 receptor activation is necessary, but not sufficient, to trigger transcription factor expression. Because cocaine blocks uptake of norepinephrine (NE) and serotonin (5-HT), as well as DA, we examined whether cocaine's ability to inhibit NE and 5-HT uptake may contribute to its induction of c-fos and zif268 expression in striatum. In examining the effects of selective monoamine uptake inhibitors, we observed that fluoxetine or citalopram, selective inhibitors of 5-HT uptake, potentiated the ability of mazindol, a DA and NE uptake inhibitor, to induce zif268 and c-fos expression, even though these 5-HT uptake inhibitors had no effect when administered alone. In contrast, the selective NE uptake inhibitor, desipramine, administered alone, or in combination with fluoxetine, did not increase expression of zif268 or c-fos. Furthermore, selective denervation of 5-HT projections by p-chloroamphetamine treatment attenuated the increase in zif268 and c-fos expression induced by cocaine in the striatum. In contrast, selective lesions of NE projections with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine hydrochloride failed to block cocaine's activation of these genes in the striatum. Taken together, these findings indicate that cocaine's ability to induce striatal expression of c-fos and zif268 is mediated by its effects on both the 5-HT and DA systems.
Similar articles
-
5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.Synapse. 1998 Sep;30(1):71-8. doi: 10.1002/(SICI)1098-2396(199809)30:1<71::AID-SYN9>3.0.CO;2-H. Synapse. 1998. PMID: 9704883
-
Effects of amphetamine and cocaine treatment on c-Fos, Jun-B, and Krox-24 expression in rats with intrastriatal dopaminergic grafts.Exp Neurol. 1999 Sep;159(1):139-52. doi: 10.1006/exnr.1999.7129. Exp Neurol. 1999. PMID: 10486183
-
Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum.J Comp Neurol. 1995 Mar 6;353(2):200-12. doi: 10.1002/cne.903530204. J Comp Neurol. 1995. PMID: 7745131
-
Role of monoamine systems in activation of zif268 by cocaine.J Psychiatry Neurosci. 1992 Sep;17(3):94-102. J Psychiatry Neurosci. 1992. PMID: 1356432 Free PMC article. Review.
-
Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs.Can J Neurol Sci. 1991 Aug;18(3 Suppl):380-3. doi: 10.1017/s0317167100032480. Can J Neurol Sci. 1991. PMID: 1682022 Review.
Cited by
-
Activation of the cGMP pathway in dopaminergic structures reduces cocaine-induced EGR-1 expression and locomotor activity.J Neurosci. 2004 Nov 24;24(47):10716-25. doi: 10.1523/JNEUROSCI.1398-04.2004. J Neurosci. 2004. PMID: 15564589 Free PMC article.
-
Enhanced locomotor, reinforcing, and neurochemical effects of cocaine in serotonin 5-hydroxytryptamine 2C receptor mutant mice.J Neurosci. 2002 Nov 15;22(22):10039-45. doi: 10.1523/JNEUROSCI.22-22-10039.2002. J Neurosci. 2002. PMID: 12427861 Free PMC article.
-
First evidence that drugs of abuse produce behavioral sensitization and cross sensitization in planarians.Behav Pharmacol. 2010 Jul;21(4):301-13. doi: 10.1097/FBP.0b013e32833b0098. Behav Pharmacol. 2010. PMID: 20512030 Free PMC article.
-
Mediating the effects of drug abuse: the role of Narp in synaptic plasticity.ILAR J. 2011;52(3):321-8. doi: 10.1093/ilar.52.3.321. ILAR J. 2011. PMID: 23382146 Free PMC article. Review.
-
Vilazodone, a Novel SSRI Antidepressant with 5-HT1A Partial Agonist Properties: Diminished Potentiation of Chronic Oral Methylphenidate-Induced Dynorphin Expression in the Striatum in Adolescent Male Rats.Mol Neurobiol. 2025 Apr;62(4):4520-4532. doi: 10.1007/s12035-024-04569-8. Epub 2024 Oct 28. Mol Neurobiol. 2025. PMID: 39466575 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous